| 摘要 |
The present invention exploits the discovery that amounts of uracil and thymine metabolites, especially beta-aminoisobutyric acid, in various bodily fluids, especially urine, are correlated with the occurrence of epilepsy when compared to matched control subjects. Analytical and diagnostic protocols, including a novel high performance liquid chromatography system, for use in the invention are disclosed.
|
